The Tuschl Lab secure further funding

The Tuschl lab secure further funding from:

GOSH BRC Junior Faculty Consumable Support (£10,000): to develop antisense oligonucleotide treatment for manganese neurotoxicity.

&

UCL Therapeutic Innovation Networks (TINs) Pilot Data Scheme – Small Molecules (£10,000): to develop novel chelators for the treatment of manganese neurotoxicity in collaboration with the group of Prof John Spencer and Dr George Lostakis at the University of Sussex.